课题基金 / 基金详情

LncRNA in Alzheimer's Disease-Associated Neuroinflammation and Neurodegeneration

LncRNA in Alzheimer's Disease-Associated Neuroinflammation and Neurodegeneration
LncRNA 在阿尔茨海默病相关的神经炎症和神经变性中的作用
批准号:
10289294
负责人:
Hitendra Singh Chand
金额:
$13.36万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-03 至 2022-08-31
关键词:
3xTg-AD mouseAblationAddressAdministrative SupplementAgingAlternative SplicingAlzheimer associated neurodegenerationAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAntisense RNAArchivesAstrocytesAutoimmunityAutopsyBindingBrainCD4 Positive T LymphocytesCell Adhesion MoleculesCell Culture TechniquesCell physiologyCellsChronicClinical ResearchCrossbreedingDataDepositionDevelopmentEpithelial CellsEtiologyExhibitsFluorescent in Situ HybridizationFunctional disorderFutureGeneticGenetic TranscriptionGlial Fibrillary Acidic ProteinGoalsGrantHIVHIV InfectionsHIV-1HIV-associated neurocognitive disorderHealthHigh PrevalenceImmunologyImpaired cognitionImpairmentIncidenceInfectionInflammationInflammatoryInflammatory ResponseIntercellular adhesion molecule 1InterventionJournalsLengthLife ExpectancyLongevityMAPT geneMediatingMembrane GlycoproteinsMemory LossMicroRNAsMicrogliaModelingMolecularMucous MembraneMusNerve DegenerationNeurocognitiveNeurofibrillary TanglesNeuronsParentsPathogenesisPathologicPathologyPatientsPatternPhosphorylationPopulationPoriferaPublishingRegulationResearchRoleSenile PlaquesSynapsesSynaptic TransmissionTauopathiesTemporal LobeTestingTissuesTranscriptTransgenic MiceTranslatingUntranslated RNAViremiaVirus Diseasesabeta accumulationaging populationairway epitheliumantiretroviral therapybrain tissuechromatin modificationcomorbiditydensitydisorder controlimmune activationimprovedin silicoin vivoinduced pluripotent stem cellinsightloss of functionmRNA Decaymouse modelneurocognitive disorderneuroinflammationneuropathologynoveloverexpressionpreventrecruitresponsesensortau Proteinstau aggregationthree dimensional structure

项目摘要

项目成果

Hitendra Singh Chand的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 R21基金的目的是:1)直接调节气道上皮细胞中的lncRNA LASI水平, 通过功能获得和功能丧失研究确定LASI调节的机制 通过分析其作为微RNA或微蛋白的前体,或作为 海绵结合microRNA。因此,亲本R21中的三个主要焦点是lncRNA LASI, 炎症反应和HIV-1感染。在这里,我们想把这三大重点的范围拓宽 通过评估lncRNALASI减轻阿尔茨海默病小鼠模型神经炎症的潜力, 疾病(AD)以及艾滋病毒和AD的共病模型,这是一个主要的健康问题, 近年在初步研究中,LASI在尸检大脑颞叶皮层区域的转录水平 AD患者的组织高度上调,并与增加的神经病理学相关, 与来自未受影响的对照受试者的组织相比,神经炎症。更重要的是,LASI的消融 表达直接调节细胞炎症反应。这些数据表明,LASI lncRNA转录物是神经炎性反应的重要调节剂, LASI的表达导致神经炎症和AD相关的神经变性的加重。 引人注目的是,AD相关的病理在HIV感染人群中高度流行,但知之甚少 潜在的分子机制。在此,我们建议在初步研究的基础上, 并确定HIV感染是否进一步加剧AD相关的神经炎症, 在其中扮演的角色。目标1中的研究将通过在CNS中采用基因编辑来询问LASI的作用 AD和HIV感染的细胞培养模型,在特定目标2中,与LASI相互作用以篡改的分子实体 将研究神经炎症。可能与LASI转录本相互作用的miRNA-150- 5 p的作用 并将研究它们与HIV或LPS诱导的神经炎症的关系。LASI的体内靶向 将使用转基因小鼠测试其在调节神经炎性病理中的作用 AD病理学和HIV感染的模型。因此,我们计划直接在小鼠中测试lncRNA LASI的效果。 HIV(iTAT-Tg)和AD(3xTg-AD)的模型,并解决HIV/AD研究中的三个关键问题,即,艾滋病毒和 AD合并症、神经炎症和AD相关病理,包括Aβ斑块和神经炎性病变 缠结,这一行政补充请求与阿尔茨海默病和相关痴呆症直接相关 (ADRD).如果靶向lncRNA LASI成功减轻神经炎症和淀粉样蛋白斑块/缠结, 将来可能会转化为临床研究。
英文摘要
PROJECT ABSTRACT The objectives of the parent R21 grant are: 1) to directly modulate the lncRNA LASI levels in airway epithelial cells by gain- and loss-of-function studies; and 2) to identify the mechanisms by which LASI modulates inflammatory responses by analyzing its potential as the precursor for microRNAs or microproteins, or as the sponge that binds the microRNAs. Thus, the three major focuses in the parent R21 are lncRNA LASI, inflammatory responses and HIV-1 infection. Here, we want to broaden the scope of these three major focuses by also evaluating the potential of lncRNA LASI to mitigate neuroinflammation in a mouse model of Alzheimer’s disease (AD) as well as a comorbidity model of HIV and AD which is emerging as a major health problem in recent years. In the preliminary studies, LASI transcript levels in the temporal cortical regions in autopsied brain tissues of patients with AD were highly upregulated and correlated with the increased neuropathologies and neuroinflammation compared to tissues from unaffected control subjects. More importantly, ablation of LASI expression directly modulates the cellular inflammatory responses. Together these data thus suggest that LASI lncRNA transcripts are an important modulator of neuroinflammatory responses, and the dysregulated expression of LASI results in the exacerbated neuroinflammation and AD-associated neurodegeneration. Strikingly, the AD-related pathologies are highly prevalent among HIV-infected population and not much is known about the underlying molecular mechanisms. Here, we propose to further develop upon our preliminary studies and determine whether HIV-infection further exacerbates the AD-associated neuroinflammation and determine the role of LASI therein. Studies in Aim 1 will interrogate the role of LASI by employing genetic editing in CNS cell culture models of AD and HIV infection, In Specific Aim 2, molecular entities that interact with LASI to tamper the neuroinflammation will be investigated. Role of miRNA-150-5p that potentially interacts with LASI transcripts and their association with HIV- or LPS-induced neuroinflammation will be investigated. In-vivo targeting of LASI will be tested for evaluating its role in modulating the neuroinflammatory pathologies using the transgenic mouse models of AD pathologies and HIV infection. Since, we plan to test the effect of lncRNA LASI directly in a mouse model of HIV (iTAT-Tg) and AD (3xTg-AD) and address three key questions in HIV/AD research, i.e., HIV and AD comorbidity, neuroinflammation, and AD-associated pathologies including Aβ plaques and neurofibrillary tangles, this administrative supplement request is directly related to Alzheimer’s disease and related dementias (ADRD). If targeting the lncRNA LASI is successful in mitigating neuroinflammation and amyloid plaques/tangles, it may be translated to the clinical studies in future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A LncRNA in Pulmonary Mucosal Immunity and HIV-Associated Comorbidities
  • 批准号:
    10013668
  • 项目类别:
  • 资助金额:
    $20.96万
  • 财政年份:
    2020
  • 负责人:
    Hitendra Singh Chand
  • 依托单位:
Targeting Hyperplastic Airway Cells Using a Small Molecule Inhibitor
海外基金